Jeryl L. Hilleman is CFO at Intersect ENT, Inc. (XENT). They have made 26 open-market trades across 4 companies since 2006, most recently 2026-07-05.
CIK 0001216628
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $5K since 2019, against 25 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| XENT | 43,836 | $1.2M |
| SIBN | 43,772 | $861K |
| OMDA | 26,519 | $468K |
| NVCR | 25,471 | $359K |
| XNPT | 25,342 | $179K |
| HLVX | 59,224 | $124K |
| NERV | 1,000 | $2K |
| AMRS | 3,599 | $180 |
| SMMX | 96,848 |
Shares reported on the most recent Form 4, priced at the 2026-07-07 close. 1 holding could not be priced and is excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NVCR | SELL | 2026-06-02 | 2026-06-03 | $15.77 | $46K | +5.6% | +3.9% | +4.3% |
| NVCR | SELL | 2025-06-03 | 2025-06-04 | $17.26 | $17K | +7.9% | +1.7% | -26.6% |
| SIBN | SELL · 10b5-1 | 2023-06-15 | 2023-06-20 | $28.49 | $178K | -5.1% | -11.9% | -20.3% |
| SIBN | SELL · 10b5-1 | 2022-06-13 | 2022-06-14 | $13.81 | $27K | +6.4% | -6.9% | +37.9% |
| NVCR | SELL · 10b5-1 | 2022-06-10 | 2022-06-16 | $69.61 | $28K | +26.9% | +26.0% | +54.4% |
| SIBN | SELL | 2021-06-25 | 2021-06-28 | $33.71 | $148K | -14.5% | -9.0% | -28.8% |
| NVCR | SELL | 2020-12-18 | 2020-12-22 | $166.40 | $416K | -4.4% | +1.1% | -17.5% |
| NERV | BUY | 2019-06-26 | 2019-06-27 | $5.25 | $5K | +19.7% | +15.1% | +49.4% |
| XENT | SELL | 2019-04-02 | 2019-04-03 | $32.34 | $686K | -11.7% | +4.0% | -32.8% |
| XENT | SELL | 2019-04-01 | 2019-04-03 | $32.23 | $2.3M | -11.7% | +4.0% | -32.8% |
| XENT | SELL | 2019-04-01 | 2019-04-03 | $32.07 | $962K | -11.7% | +4.0% | -32.8% |
| XENT | SELL | 2018-10-08 | 2018-10-10 | $27.99 | $718K | -7.3% | +4.2% | -10.6% |
| XENT | SELL | 2018-09-14 | 2018-09-18 | $28.92 | $742K | -3.4% | -1.1% | -2.4% |
| XENT | SELL | 2018-06-05 | 2018-06-07 | $41.70 | $1.1M | -10.6% | -14.8% | -29.0% |
| XENT | SELL | 2018-05-03 | 2018-05-07 | $39.94 | $1.0M | +5.4% | +14.8% | -29.8% |
| XENT | SELL | 2018-04-03 | 2018-04-04 | $37.66 | $967K | +8.5% | +10.9% | -6.0% |
| XENT | SELL | 2018-03-06 | 2018-03-07 | $35.92 | $922K | +6.7% | -0.1% | +14.7% |
| XENT | SELL | 2018-02-06 | 2018-02-07 | $35.80 | $919K | +2.2% | +4.3% | +1.8% |
| XENT | SELL | 2018-01-11 | 2018-01-12 | $33.81 | $868K | +5.8% | +5.3% | +15.1% |
| XENT | SELL | 2017-12-04 | 2017-12-05 | $30.06 | $386K | +11.5% | +17.5% | +25.5% |
| XENT | SELL | 2017-12-04 | 2017-12-05 | $30.06 | $772K | +11.5% | +17.5% | +25.5% |
| XENT | SELL | 2017-11-06 | 2017-11-06 | $27.78 | $713K | +1.0% | -4.4% | +27.4% |
| XENT | SELL | 2017-11-06 | 2017-11-06 | $27.78 | $357K | +1.0% | -4.4% | +27.4% |
| XENT | SELL | 2017-10-04 | 2017-10-05 | $29.96 | $769K | -8.8% | -9.2% | +9.4% |
| XENT | SELL | 2017-09-05 | 2017-09-06 | $31.05 | $398K | -3.3% | -3.3% | -9.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| — |
| Total | $3.2M |